Publications by authors named "Sandra Roldan"

Claim this Profile
R
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial.
Christoph E Heilig, Christoph Heining, Editha Gnutzmann, Sandra Roldan, Laura Heiligenthal

Cancer Treat Res Communยท December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis